HAMP and acute myeloid leukemia: This finding suggests that transfusional iron remains a dominant regulator of hepcidin in these patients and that hepcidin synthesis and regulation remain intact in polytransfused patients with AML undergoing allogeneic HCT irrespective of the number of prior chemotherapies, type of conditioning regimen, or antifungal treatments.